Abstract
We report an open-label study comparing tadalafil and acetazolamide (n = 24) versus acetazolamide (n = 27) for prevention of high-altitude illness (HAI) at Mt. Kilimanjaro. Tadalafil group had lower rates of severe HAI compared with controls (4% vs 26%, p = 0.03), mostly because of decreased high-altitude pulmonary edema rates (4% vs 22%, p = 0.06). © 2012 International Society of Travel Medicine.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Cite
CITATION STYLE
Leshem, E., Caine, Y., Rosenberg, E., Maaravi, Y., Hermesh, H., & Schwartz, E. (2012). Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness. Journal of Travel Medicine, 19(5), 308–310. https://doi.org/10.1111/j.1708-8305.2012.00636.x
Readers over time
Readers' Seniority
Readers' Discipline
